Webinar | Presented on 16 Aug 2019Fewer than 50 percent of preclinical research studies, conducted at a cost of $28 billion per year, are reproducible. Rigor in bioanalytical method validation is emerging in the form of a global standard: preclinical studies are increasingly…
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends…
Western CROs continue to up their game. They are offering unique services in a marketplace where the big CROs of the east are providing an unsurpassed scale of resourcing to support the externalization of discovery services. I believe there is…
Info Sheet What is the Amazon Web Services (AWS) Well-Architected framework? The AWS Well-Architected framework has been developed to help cloud architects build secure, high-performing, resilient, and efficient infrastructure for their applications. Based on five pillars  
This year BioProduction Congress merges with bioLIVE to become BioProduction at CPhI Worldwide. BioProduction will be co-located with CPhI Worldwide in Frankfurt, 5th-7th November 2019 – the largest pharmaceutical event in the world – uniting biotech, pharma, and solution…
Want to know a secret? In September we hosted a very large group of IDBS customers from the US at i3 Nashville. Customers from every R&D industry sharing experiences, lessons learned, and business challenges. So, are you going to…